{"id":"W4379346220","doi":"10.1200/jco.2023.41.16_suppl.e21519","title":"Immune checkpoint inhibitors in advanced cutaneous squamous cell carcinoma: Real-world evidence.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Progression-free survival; Discontinuation; Population; Adverse effect; Hazard ratio; Cohort; Proportional hazards model; Log-rank test; Exact test; Cancer; Immunotherapy; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005905515,0.0004422695,0.001085114,0.0008473607,0.0001505246,0.0012785,0.0005445007,0.001068326,0.005773537],"category_scores_gemma":[0.007669717,0.0001602155,0.001971941,0.001342015,0.0003808858,0.0009034291,0.0004304902,0.0008444835,0.0006731998],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004720796,"about_ca_system_score_gemma":0.0007018677,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005692434,"about_ca_topic_score_gemma":0.001535476,"domain_scores_codex":[0.9978848,0.001051387,0.0004539167,0.0001885586,0.0003395284,0.00008173847],"domain_scores_gemma":[0.9879799,0.007247251,0.003572371,0.0002844528,0.0006631015,0.0002529262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03904245,0.001429034,0.07099847,0.06267767,0.0124915,0.0003899136,0.000104709,0.001197777,0.001226835,0.001035025,0.008142747,0.8012639],"study_design_scores_gemma":[0.0563691,0.06448276,0.4321224,0.1209634,0.07571817,0.006407853,0.001107454,0.004180305,0.003868897,0.003990693,0.2305378,0.0002512834],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.07207508,0.9197922,0.0002297342,0.002573251,0.0002858952,0.0002299097,0.00120074,0.00001270223,0.003600524],"genre_scores_gemma":[0.4951305,0.4956713,0.0008258319,0.004139422,0.001195983,0.0002038004,0.00188151,0.00001058544,0.0009409618],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.005905515,"threshold_uncertainty_score":0.0312317,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1081467984445015,"score_gpt":0.4475976401977972,"score_spread":0.3394508417532957,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}